Filter
246
Filtered Results: 246
Text search:
Rabies
Information
System
of
the
World
Health
Organization
WHO
Featured
Recommendations
35
New Publications
92
Language
Document type
No document type
125
Studies & Reports
43
Guidelines
30
Strategic & Response Plan
25
Manuals
13
Fact sheets
6
Training Material
2
Situation Updates
2
Countries / Regions
Liberia
16
Global
10
Philippines
9
Kenya
9
Ethiopia
8
Africa
8
India
7
Sierra Leone
5
Zambia
5
Indonesia
5
Bangladesh
5
Nigeria
4
Ghana
4
Uganda
4
Nepal
4
Guinea
3
Zimbabwe
3
Tanzania
3
Rwanda
3
Mozambique
3
Ukraine
3
Myanmar / Burma
3
East and Southern Africa
3
West and Central Africa
3
Papua New Guinea
2
Sudan
2
Namibia
2
Libya
2
South–East Asia Region
2
Latin America and the Carribbean
2
Western and Central Europe
2
Senegal
1
Congo, Democratic Republic of
1
Mali
1
Saudi Arabia
1
Cameroon
1
Somalia
1
Pakistan
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Turkey
1
Egypt
1
Syria
1
South Africa
1
Malawi
1
Central African Republic
1
Brazil
1
Botswana
1
Yemen
1
Middle East and North Africa
1
Western Pacific Region
1
Paraguay
1
Venezuela
1
Eastern Europe
1
Palestine
1
Djibouti
1
Timor Leste/ East Timor
1
Qatar
1
Iran
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
118
Clinical Guidelines
27
Public Health
9
Key Resources
9
Capacity Building
8
Women & Child Health
7
Pharmacy & Technologies
2
Toolboxes
NTDs
28
Planetary Health
23
Pharmacy
18
Rapid Response
16
AMR
13
Ebola
9
COVID-19
9
Conflict
3
Natural Hazards
3
Global Health Education
3
Refugee
2
Mental Health
2
TB
2
NCDs
2
Cholera
1
Polio
1
Zika
1
Specific Hazards
1
Caregiver
1
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephanti...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available ... critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the manual is available in a compiled form and in several separate modules that can be consulted individually. For each module, specific training material is also available to facilitate implementation.
2nd. edition
The new edition has been developed to make widely available to programme managers, health care workers in endemic settings, academic researchers, and other key partners, a concise sour...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about ...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines...
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. ... Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the fact that the genetic sequence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had been shared worldwide. It was noted that in one country SARS-CoV-2 had been reconstructed in a laboratory from the viral genome sequence before the first case of COVID-19 had been reported, highlighting the benefits of synthetic biology technologies for accelerated development of diagnostics as well as the oft-described potential risks. Lessons learned about clinical care during the COVID-19 pandemic were also discussed.
The objective of Health in the Americas: Overview of... the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional importance. This 2022 edition is the second in its new format, providing an overview of the analysis, as well as an in-depth description of the key issues related to COVID-19 in the Region of the Americas. This overview is supported by the Health in the Americas+ virtual platform, which offers interactive resources for data analysis and allows for the comparison of information disaggregated by subregions and countries.
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium ... indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators presented in the M&E framework. These indicators will also support reporting on strategies described in other road map companion documents to guide action against neglected tropical diseases include the sustainability framework, the global strategy on water, sanitation and hygiene, the One Health approach and the strategic framework for integrated control and elimination of skin-related neglected tropical diseases.
The purpose of this compendium is to guide monitoring and evaluation of programmes and thereby to improve their quality and effectiveness in alignment with the road map goals. It provides a standardized listing of the most widely used indicators relevant to countries, with uniformity in defining indicators to allow comparisons over time and among different programmes. Detailed metadata are provided for each of these indicators to facilitate validity, internal consistency, standardized measurement, estimation methods and comparability of data across countries.
Connecting global priorities: biodiversity and human health: a state of knowledge review
The World Health Organization Regional Office for Africa (... AFRO), in accordance with recommendations from various WHO committees, has developed three flagship initiatives to support Member States in the African region to prepare for, detect and respond to public health emergencies. They are the result of extensive consultations with more than 30 African government ministers, technical actors, and partners across the continent as well as regional institutions such as the Africa Centres for Disease Control and Prevention (Africa CDC), whose contributions have shaped the priority activities. This report provides the fourth quarterly summary of progress in implementing the flagship initiatives.
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medi...
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health produ...
Driving progress towards rabies elimination: Results of Gavi’s Learning Agenda on rabies and new WH... position on rabies immunization
The Quadripartite Organizations – the Food and Agriculture Organization ... the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Organisation for Animal Health (WOAH, founded as OIE), and the World Health Organization (WHO) – collaborate to drive the change and transformation required to mitigate the impact of current and future health challenges at the human–animal– plant–environment interface at global, regional and country level.
Report of the 23rd WHO Expert Committee on the selection and use ... essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc).
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and formulation on the Model Lists of Essential Medicines. The Committee evaluated the scientific evidence for comparative effectiveness, safety and cost-effectiveness of the medicines in question. The Committee also considered a review of the therapeutic alternatives for medicines on the Model Lists, and update to the AWaRe classification of antibiotics, and reviews and reports relevant to the selection and use of essential medicines.
Health Evidence Network synthesis report 53
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global i...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–2...
